Shares of Goleta-based Inogen settled into the low $15 range as the Business Times went to press Feb. 19 after the company raised $70.5 million in an initial public offering that priced at $16, the low end of its expected range. In addition to selling shares, the company changed some of the disclosures it made to investors, pointing out its steep reliance on government and private insurance programs for 41 percent of its total revenue in 2012.
Goleta-based Inogen has raised $70.5 million in an initial public offering of 4.4 million shares priced at $16, the bottom of the expected $16 to $18 a share range, according to IPO investment firm Renaissance Capital.
Camarillo-based Told Corp., one of the most prolific developers in the Tri-Counties, recently closed a three-way deal that added another industrial property to its portfolio and allowed it to retain two important tenants.
Goleta-based Inogen has boosted the amount it plans to raise in its initial public offering to a possible $91.3 million. The pricing is a sign that Inogen and its underwriters — J.P. Morgan, Leerink Partners, William Blair and Stifel — believe there’s strong demand for its shares.
If Goleta-based Inogen goes public this year, it will be the first firm in the region to do so under new securities rules that make it easier for small companies to become listed on the major exchanges but also allow them to reveal less information to investors than their larger counterparts.
By Henry Dubroff / Friday, January 24th, 2014 / Columns, Opinion / Comments Off on Political scuffle spotlights Goleta revenue-sharing deal with county
Renegotiating the RNA has emerged as a potentially explosive issue in the 2014 election where Goleta City Councilman Roger Aceves is challenging incumbent Janet Wolf for the 2nd District seat, which represents part of Goleta.
CEO Mike Sheldon said the company has been aggressively pursuing a “growth through diversification” strategy, adding maintenance services as well as servers and hard drives to its product lineup.
